Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma.
Saved in:
| Title: | Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma. |
|---|---|
| Authors: | Filip D; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Litzmanova K; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Michaelou A; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Faculty of Science, Masaryk University, Brno, Czech Republic., Kledus F; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Faculty of Science, Masaryk University, Brno, Czech Republic., Devan J; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Boudny M; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Hoferkova E; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Sharma S; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Seda V; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Zeni PF; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Faculty of Science, Masaryk University, Brno, Czech Republic., Borsky M; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Matulova K; Dept of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kren L; Dept of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Oppelt J; Bioinformatics Core Facility, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Blavet N; Bioinformatics Core Facility, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Hejret V; Bioinformatics Core Facility, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Urik M; Dept of Pediatric Otorhinolaryngology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Mareckova A; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Rimsza LM; Dept of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.; University of Arizona in Tucson, Tucson, AZ, USA., Kamaradova K; The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital Hradec Kralove, Kralove, Czech Republic., Belada D; The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital Hradec Kralove, Kralove, Czech Republic., Sykorova A; The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital Hradec Kralove, Kralove, Czech Republic., Mocikova H; Dept of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic., Trneny M; 1st Department of Medicine - Department of Hematology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic., Prouzova Z; Dept of Pathology, University, Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic., Evans AG; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Danilov A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Horn H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany., Ott G; Dept of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany., Staber P; Dept of Medicine I, Medical University of Vienna, Vienna, Austria.; Dept of Internal Medicine 1, Saarland University Medical School, Homburg/Saar, Germany., Mayer J; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Janikova A; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Mraz M; Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic. 101627@mail.muni.cz.; Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic. 101627@mail.muni.cz. |
| Source: | Leukemia [Leukemia] 2026 Apr; Vol. 40 (4), pp. 759-772. Date of Electronic Publication: 2026 Feb 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
